High EGFR expression in NSCD10s also meets a potential for molecular target therapy, which has been verified in some solid tumours, such as colorectal cancer, non-small-cell lung cancer and squamous cell carcinoma of the head and neck [19-21]. This evidence concerns the gene EGFR and colorectal cancer.